Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000899243-15-005094

Chief Operating Officer sold 680 shares at $6.33 ($4,304)

From the SEC's structured data for this filing

Trades in this filing

Keuer Thomas A · Chief Operating Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2015-09-18 Sale : show line 1 in the form −680 $6.33 $4,304 17,407 D
Open-market sales · 680 sh · avg $6.33 · $4,304
Loading xslF345X03/doc4.xml…